gototopgototop

Main Menu

Name:
Dr. K. Ganesan
Expertise:
Yeast Genetics & Molecular Biology.

Contact Address:

Institute of Microbial Technology,
Sector 39-A, Chandigarh-160036.
Email: ganesan@imtech.res.in
Fax:   +91-172-2690585 & 2690632
Phone: +91-172-2636680 to 94 Ext. 3290

Write-up of research and development interests/focus, past and present goals:

Molecular mechanisms of Amphotericin B resistance in Candida


Candida albicans and several other Candida species are present as benign commensals in one or more body locations in a majority of healthy humans. However, especially in immunocompromised patients, Candida becomes an opportunistic pathogen that can cause superficial as well as severe, life-threatening systemic infections. There is also an increase in the number of clinical isolates resistant to amphotericin B, a frontline antifungal, frequently resulting in treatment failures. Hence, we are trying to identify and characterize genes and regulatory pathway(s) that are involved in amphotericin B resistance. A molecular level understanding of this phenomenon is likely to help in devising strategies to minimize development of resistance during therapy. Besides the above, we have also developed novel molecular genetic tools for conditional expression of C. albicans genes, which will facilitate rapid determination of gene function in this species.


Metabolic engineering of yeast for ethanol production


Fermentative production of ethanol from renewable biomass is an attractive source of energy. A thermotolerant yeast strain that can efficiently ferment sugars from raw materials such as molasses, at up to 38°C, was developed and patented by us earlier. However, this strain, like other S. cerevisiae strains, can not ferment xylose. Xylose can constitute as much as thirty percent of biomass, and its efficient fermentation is critical for cost effective production of ethanol. Thus, in collaboration with other groups at IMTECH, we are engineering the thermotolerant strain for xylose fermentation by introducing genes encoding two enzymatic steps of xylose metabolic pathway from another yeast species.  The xylulose kinase of S. cerevisiae is also being overexpressed by replacing its promoter with a strong constitutive promoter. Substantial progress has already been made in constructing such a strain. Work is underway to improve this strain further for efficient fermentation of xylose.


Selected list of Publications and Patents:

  • Sharma VM & Ganesan K (2003) "Method for the simultaneous monitoring of individual mutants in mixed populations", United States Patent # 6,528,257.


  • Ganesan K, GS Prasad, Vishva Mitra Sharma, Indrani Ghosh, Rohini Chopra & Tapan Chakrabarti (2003) "An improved process for the production of alcohol using improved thermotolerant flocculent strains of yeast Saccharomyces”, Indian Patent # 189737.


  • Amin-ul Mannan M, Sharma S & Ganesan K (2009) Total RNA isolation from recalcitrant yeast cells. Anal Biochem389: 77-79.


  • Puria R, Amin-ul Mannan M, Chopra-Dewasthaly R & Ganesan K (2009) Critical role for RPI1 in stress tolerance of yeast during ethanolic fermentation. FEMS Yeast Res (under revision).


  • Taneja V, Paul S & Ganesan K (2004) Directional ligation of long-flanking homology regions to selection cassettes for efficient targeted gene-disruption in Candida albicans. FEMS Yeast Res 4: 841-847.


  • Sharma VM, Chopra R, Ghosh I & Ganesan K (2001) Quantitative target display: a method to screen yeast mutants conferring quantitative phenotypes by 'mutant DNA fingerprints'. Nucleic Acids Res29: E86-86.


  • Chopra R, Sharma VM & Ganesan K (1999) Elevated growth of Saccharomyces cerevisiae ATH1 null mutants on glucose is an artifact of nonmatching auxotrophies of mutant and reference strains. Appl Environ Microbiol 65: 2267-2268.

This site is best viewed in Mozilla Firefox, Internet Explorer 8 and above at screen resolution of 1024 x 768 and above.